Brain choline acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin

Molecular Psychiatry

Volumn 4, Issue 1, 1999, Pages 26-32

  Kish, S J ^a   Kalasinsky, K S ^b   Furukawa, Y ^a   Guttman, M ^a   Lang, A ^c   Li, L ^d   Adams, V ^e   Reiber, G ^f   Anthony, R A ^f   Anderson, W ^g   Smialek, J ^d   DiStefano, L ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e Office of the Hillsborough County Medical Examiner   (United States)

^f N California Forensic Pathology   (United States)

^g Off of the Med Examiner of D   (United States)

Author keywords

Acetylcholine; Choline acetyltransferase; Cocaine; Cognitive disorder; Dopamine; Heroin; Methamphetamine; Nucleus basalis

Indexed keywords

BRAIN ENZYME; CHOLINE ACETYLTRANSFERASE; COCAINE; DIAMORPHINE; METHAMPHETAMINE;

ARTICLE; AUTOPSY; BRAIN CORTEX; CHOLINERGIC NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; NEUROCHEMISTRY; PRIORITY JOURNAL; THALAMUS;

EID: 0033006830     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000462     Document Type: Article

References (29)

1. 1 Manschreck TC, Schneyer ML, Weisstein CC, Laughery J, Rosenthal J, Celada T et al. Freebase cocaine and memory. Comprehensive Psychiatry 1990; 31: 369-375.
2. 2 Ardila A, Rosselli M, Strumwasser S. Neuropsychological deficits in chronic cocaine abusers. Int J Neurosci 1991; 57: 73-79.
3. 3 O'Malley S, Adamse M, Heaton RK, Gawin FH. Neuropsychological impairment in chronic cocaine abusers. Am J Drug Alcohol Abuse 1992; 18: 131-144.
4. 4 Berry J, van Gorp WG, Herzberg DS, Hinkin C, Boone K, Steinman L et al. Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. Drug Alcohol Depend 1993; 32: 231-237.
5. 5 Strickland TL, Mena I, Villanueva-Meyer J, Miller BL, Cummings J, Mehringer CM et al. Gerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiat Clin Neurosci 1993; 5: 419-427.
6. 6 Tarter RE, Mezzich AC, Hsieh Y-C, Parks SM. Cognitive capacity in female adolescent substance abusers. Drug Alcohol Depend 1995; 39: 15-21.
7. 7 Bauer L. Psychomotor and electroencephalographic sequelae of cocaine dependence. NIDA Research Monograph 1996; 163: 66-93.
8. 8 Noldt NE, Carlen PL. Event-related potential changes in cocaine withdrawal: evidence for long-term cognitive deficits. Neuropsychobiology 1997; 36: 53-56.
9. 9 Ollo C, Lindquist T, Alim TN, Deutsch SI. Predicting premorbid functioning in crack-cocaine abusers. Drug Alcohol Depend 1995; 40: 173-175.
10. 10 Derlet RW, Rice P, Horowitz BZ, Lord RV. Amphetamine toxicity: experience with 127 cases. J Emerg Med 1989; 7: 157-161.
11. 11 Voytko ML, Olton DS, Richardson RT, Gorman LK, Tobin JR, Price DL. Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J Neurosci 1994; 14: 167-186.
12. 12 Kish SJ, El-Awar M, Stuss D, Nobrega J, Curier R, Aita JF et al. Neuropsychological test performance in patients with dominantly inherited spinocerebellar ataxia: relationship to ataxia severity. Neurology 1994; 44: 1738-1746.
13. 13 Lawrence AD, Sahakian BJ. Alzheimer's disease, attention, and the cholinergic system. Alz. Dis Assoc Disord 1995; 9 (Suppl 2): 43-49.
14. 14 Wilson JM, Levey AI, Bergeron C, Kalansinsky K, Ang L, Peretti F et al. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronio cocaine users. Ann Neurol 1996; 40: 428-439.
15. 15 Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM et al. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Med 1996; 2: 690-703.
16. 16 Riley HA. An Atlas of the Basal Ganglia, Brainstem, and Spinal Cord. Hafner: New York, 1960.
17. 17 Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N. Engl J Med 1988; 318: 867-880.
18. 18 Hortnagl H, Schlogl E, Sperk G, Hornykiewicz O. The topographical distribution of the monoaminergic innervation in the basal ganglia of the human brain. Prog Brain Res 1983; 58: 269-274.
19. 19 Fonnum F. A rapid radioenzymatic method for the determination of choline acetyltransferase. J Neurochem 1975; 24: 407-409.
20. 20 Mastrogiacomo F, Lindsay JG, Bettendorff L, Rice J, Kish SJ. Brain protein and α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. Ann Neurol 1996; 39: 592-598.
21. 21 Kish SJ, Lopes-Cendes I, Guttman M, Furukawa Y, Pandolfo M, Rouleau GA et al. Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeal disorders. Arch Neurol 1998 (in press).
22. 22 Baselt R, Cravey B. Disposition of Toxic Drugs and Chemicals in Man. Chemical Toxicology Institute: Foster City, CA, 1995.
23. 23 Karch SB. The Pathology of Drug Abuse. CRC Press: Boca Raton, FL, 1996.
24. 24 Palmer AM. Neurochemical studies of Alzheimer's disease. Neuro-degeneration 1996; 5: 381-391.
25. 25 Kish SJ, Kleinert R, Minauf M, Gilbert J, Walter GF, Slimovitch C et al. Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome. Am J Psychiat 1990; 147: 1358-1363.
26. 26 Kosten TR, Kleber HD. Rapid death during cocaine abuse: a variant of the neuroleptic malignant syndrome? Am J Drug Alcohol Abuse 1988; 14: 335-346.
27. 27 Gaspar D, Davies P. Mechanism of activation of choline acetyl-transferase in cultured human neuroblastoma. Brain Res 1981; 218: 85-94.
28. 28 Hersh LB. Induction of choline acetyltransferase in the neuroblastoma × glioma cell line NG108-15. Neurochem Res 1992; 11: 1063-1067.
29. 29 Baberg HT, Nelesen RA, Dinisdale JE. Amphetamine use: return of an old scourge in a consultation psychiatry setting. Am J Psychiat 1996; 153: 789-793.